Search Prime Grants

HT94252410852

Project Grant

Overview

Grant Description
Spatiotemporal specificity of NF1 dimerization
Awardee
Biomedical Sciences Research Center Alexander Fleming
Funding Goals
NEUROFIBROMATOSIS RESEARCH PROGRAM AWARD MECHANISM: EXPLORATION - HYPOTHESIS DEVELOPMENT AWARD
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Greece
Geographic Scope
Foreign
Related Opportunity
HT942523NFRPEHDA
Analysis Notes
Amendment Since initial award the End Date has been shortened from 07/31/27 to 07/31/26.
Biomedical Sciences Research Center Alexander Fleming was awarded Project Grant HT94252410852 worth $124,980 from Defense Health Agency in August 2024 with work to be completed primarily in Greece. The grant has a duration of 2 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 7/31/25

Period of Performance
8/1/24
Start Date
7/31/26
End Date
88.0% Complete

Funding Split
$125.0K
Federal Obligation
$0.0
Non-Federal Obligation
$125.0K
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HT94252410852

Transaction History

Modifications to HT94252410852

Additional Detail

Award ID FAIN
HT94252410852
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
ESJ2UFQVSBN9
Awardee CAGE
G0991
Performance District
Not Applicable
Modified: 7/31/25